Principal Financial Group
MRVI icon

Principal Financial Group’s Maravai LifeSciences MRVI Stock Holding History

Principal Financial Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-352,600
Closed -$2.93M – 2236
2024
Q3 		$2.93M Sell
352,600
-313,587
-47% -$2.71M ﹤0.01% 1711
2024
Q2 		$4.77M Buy
666,187
+255,990
+62% +$2.21M ﹤0.01% 1566
2024
Q1 		$3.56M Buy
410,197
+398,306
+3,350% +$2.69M ﹤0.01% 1673
2023
Q4 		$77.9K Hold
11,891
– – ﹤0.01% 2295
2023
Q3 		$119K Buy
11,891
+797
+7% +$8.75K ﹤0.01% 2257
2023
Q2 		$138K Sell
11,094
-649
-6% -$8.76K ﹤0.01% 2235
2023
Q1 		$165K Sell
11,743
-2,206
-16% -$31.7K ﹤0.01% 2219
2022
Q4 		$200K Sell
13,949
-40,192
-74% -$633K ﹤0.01% 2196
2022
Q3 		$1.38M Sell
54,141
-587,208
-92% -$14.7M ﹤0.01% 1785
2022
Q2 		$18.2M Buy
641,349
+139,667
+28% +$4.42M 0.01% 888
2022
Q1 		$17.7M Sell
501,682
-69,025
-12% -$2.31M 0.01% 1001
2021
Q4 		$23.9M Sell
570,707
-44,634
-7% -$1.81M 0.01% 824
2021
Q3 		$30.2M Buy
615,341
+122,409
+25% +$5.97M 0.02% 649
2021
Q2 		$20.6M Buy
492,932
+486,275
+7,305% +$18.8M 0.01% 955
2021
Q1 		$237K Buy
+6,657
New +$221K ﹤0.01% 2338

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group's MRVI Position: Q4 2024 in Review

Principal Financial Group sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 352,600 shares — an estimated $2.93M sold.

Principal Financial Group first reported a position in MRVI in Q1 2021 and held it in 15 quarters. The position peaked at $30.2M in Q3 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • Principal Financial Group reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Principal Financial Group sold 352,600 Maravai LifeSciences shares in Q4 2024, an estimated $2.93M.
  • Principal Financial Group first reported a position in Maravai LifeSciences in Q1 2021 and held it in 15 quarters.
  • Principal Financial Group's Maravai LifeSciences position peaked at $30.2M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Principal Financial Group's 13F filing for Q4 2024, filed 31 Jan 2025.